Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

FoxHollow loses CEO: President & CEO Robert Thomas resigns, effective Jan. 1. Thomas, who joined the SilverHawk plaque excision system manufacturer in 1998 and has been CEO since 2000, announced plans to retire Dec. 12. Founder and Chairman John Simpson steps in as interim CEO while the firm searches for a permanent replacement. The 44-year-old Thomas cited personal reasons for his departure, but some analysts question that explanation, according to reports in the Wall Street Journal. FoxHollow's stock has fallen sharply, closing Jan. 5 at $30.12, down 35% from $46.44 Dec. 9, the last trading day before the announcement...
Advertisement

Related Content

FoxHollow Stock Up 25% In Q3 On SilverHawk Profitability, Merck Deal
FoxHollow Stock Up 25% In Q3 On SilverHawk Profitability, Merck Deal
FoxHollow Delays Pursuit Of SilverHawk Coronary Artery Disease Indication
People In Brief
JP Morgan Healthcare Conference In Brief
Guidant Shareholders To Vote On J&J Offer; Boston Scientific Still Interested
AngioDynamics Foresees New Laser Sales Opportunities With Sotradecol Drug
FDA’s Ortho Panel To Consider Study Designs For Less Invasive Spinal Devices
ResMed Collaborates With Rival To Raise Awareness Of Sleep Disorders
ResMed Collaborates With Rival To Raise Awareness Of Sleep Disorders
Advertisement
UsernamePublicRestriction

Register

MT023085

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel